GET THE APP

Pandemic Response created Gulf between Science and Scientific Methods
..

Journal of Biomedical and Pharmaceutical Sciences

ISSN: 2952-8100

Open Access

Pandemic Response created Gulf between Science and Scientific Methods


14th International Conference on Pharmaceutical Education and Practice

October 28, 2022 | Webinar

Obaid Ali

O.R. Centre for Quality Sciences, Pakistan

Keynote: Biomedical & Pharmaceutical Sciences

Abstract :

Data is the active raw material for quality product that can deliver desired output every time consistently. Information is derived from data and experience of feelings convert data into knowledge that upon practice increase wisdom and keep decisions within sensible space. Integrity of the data and its connection with the object may not be understood if relation is not established between them. To know the unknowns and to understand them is indispensable in science and scientific conclusions. Use of reliable methods, appropriate approach in scientific experiments creates certainty and uphold promises. From testing reliability of pandemic to prevention through vaccine and treatment via chemical, biological and blood products are not proven strong enough to answer the concerns and questions already set in the 21st century of pharmaceutical sciences. Multidisciplinary approach and open discussions on scientific methods used to develop and approve products among the scientific individuals are the only way to maintain grace of science and trust of common man. Focusing on expansion of learning space and feeling space in dynamic reshaping technological world can maintain the momentum of development and progress.

Biography :

Obaid Ali, a graduate of Biological Sciences and Bachelor of Pharmacy earned his MPhil in Neuropharmacology and completed his Ph.D. in Pharmaceutical Chemistry. He served Government of Pakistan as a Civil Service Officer in Drug Regulatory Authority of Pakistan for more than two decades on different key leading positions. He was an alumni of international regulatory forums of CDER, US-FDA and HPFB, Health Canada. He was a Training Consultant of WHO and completed his assignments in different countries. He is on board of different academic institutions.

arrow_upward arrow_upward